about
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief ...
Read More
1.09
0.27
(32.93%)
61.1M
XNAS Volume
High volume+gain today
XNAS 16 Jan, 2026 2:19 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
PainReform Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..